BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| (2->1)-beta-D-fructofuranan {Inulin} - Faecalibacterium prausnitzii |
📓
An Integrative Multiomics Approach to Characterize Prebiotic Inulin Effects on Faecalibacterium prausnitzii. Frontiers in bioengineering and biotechnology (Front Bioeng Biotechnol ) Vol: 10 Issue Pages: 825399 Pub: 2022 Epub: 2022 Jan 18 Authors Park JH , Song WS , Lee J , Jo SH , Lee JS , Jeon HJ , Kwon JE , Kim YR , Baek JH , Kim MG , Yang YH , Kim BG , Kim YG , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Faecalibacterium prausnitzii |
📓
Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium. Gut microbes (Gut Microbes ) Vol: 13 Issue 1 Pages: 1993582 Pub: 2021 Jan-Dec Epub: Authors Fagundes RR , Bourgonje AR , Saeed A , Vich Vila A , Plomp N , Blokzijl T , Sadaghian Sadabad M , von Martels JZH , van Leeuwen SS , Weersma RK , Dijkstra G , Harmsen HJM , Faber KN , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Faecalibacterium prausnitzii |
👶
Microbiota-Focused Dietary Approaches to Support Health: A Systematic Review. The Journal of nutrition (J Nutr ) Vol: 155 Issue 2 Pages: 381-401 Pub: 2025 Feb Epub: 2024 Oct 31 Authors Hindle VK , Veasley NM , Holscher HD , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Faecalibacterium prausnitzii |
📓
Curated database of commensal, symbiotic and pathogenic microbiota Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Faecalibacterium prausnitzii |
📓
Contribution of acetate to butyrate formation by human faecal bacteria. The British journal of nutrition (Br J Nutr ) Vol: 91 Issue 6 Pages: 915-23 Pub: 2004 Jun Epub: Authors Duncan SH , Holtrop G , Lobley GE , Calder AG , Stewart CS , Flint HJ , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
